Safe online pharmacies outside the U.S. sell popular brand name medicine at prices that average 85% lower than American pharmacies, according to our new analysis of online and local U.S. pharmacy prices. The analysis compares cash prices for top-selling brand name medications in the U.S. to prices for the same medicines abroad. All international online pharmacies in the study are licensed and require prescriptions.

The savings ranged from 82% for Celebrex to 91% for Nexium. Annual dollar savings averaged just over $3,000. The study noted the rising costs of prescription drugs in America and, perhaps surprisingly, the fact that these same drugs are becoming cheaper abroad. Average savings have increased from 80% in March, 2011.

For more information, view the press release. To view price comparisons among online pharmacies, visit PharmacyChecker.com.

Share

Prescription drug costs in the U.S. remain high, and consumers are constantly looking for ways to save. We recommend verified online pharmacies, such as those listed on PharmacyChecker.com.

However, if you need your medication immediately, an online or mail order pharmacy won’t cut it. Luckily, there are many other options to save; for example, many chain drug stores offer low cost generics and manufacturers offer coupons for their products.

Discount drug cards also offer savings and can be used in pharmacies across the United States for a wide variety of brand name and generic drugs. They seem like the perfect solution if you need medicine right away – just print the drug card, bring it to your local pharmacy, and count the savings!

But just because they can be used quickly, doesn’t mean they offer the best price on your medicine. Different drug cards carry different discounts. While one offers 70% savings on a drug, say Lipitor, another card might not have any savings at all.

There is no way to easily find the best price among different drug cards, and for some you can’t even find out the price of your medicine until you have a prescription. We investigated the prices for three different drugs for three different cards and compared them to the cash price at a local pharmacy and prices from PharmacyChecker.com-approved international online pharmacies.

As shown below, we found the average savings using the lowest-cost online pharmacy was 82%, but savings averaged only 23% across the discount drug cards. We recommend using a PharmacyChecker.com-approved online international pharmacy for brand name medications and for many generics. If you need a medicine right away, though, it’s best to print out a few drug cards and head down to the local pharmacy.

Drug Prices Using Prescription Cards vs. Online Pharmacy

Drug Bricks and Mortar Pharmacy* RxFreeCard.com EasyDrugCard.com RxSavingsPlus.com PharmacyChecker.com-approved Online Pharmacy**
Lipitor 40 mg (30) $225.99 $184.68 $178.09 $189.64 $35.00
Plavix 75 mg (30) $257.99 $214.00 $203.85 $216.74 $49.20
Simvastatin 40 mg (30) (Generic Zocor) $49.99 $4.00 $13.36 $33.30 $12.30

*Local Pharmacy in New York City, prices collected 8/20/2012
**Lowest price as listed on PharmacyChecker.com on 8/23/2012

Share

For the last six months the WSJ has actively reported on fake Avastin purchased by some medical clinics in the United States. The latest report focuses on the fact that the owner of the foreign wholesaler that shipped the fake Avastin to the U.S. is also the owner of a large international online pharmacy called CanadaDrugs.com. The WSJ reporting makes it clear that the wholesale business is separate from CanadaDrugs.com.

CanadaDrugs.com is a long-standing member of the PharmacyChecker.com Verification Program. It takes orders online filled by licensed pharmacies that require a valid prescription. It does not sell Avastin and the WSJ didn’t report any safety problems associated with its operation.

PharmacyChecker.com’s programs are designed to provide information to consumers seeking safe and affordable medication online for their own use. We recognize that importation by medical clinics does occur and the reason is that drug prices of many drugs are unusually high in the United States. We believe that wholesale drug importation presents unique drug supply and safety challenges that should be addressed but are not related to personal drug importation.

Share

Americans are speaking out against the provisions of a new law signed by President Obama on July 9th that will hinder their access to safe and affordable medication. In a news story last week on a Minneapolis-St. Paul NBC affiliate, Kare 11, we learn about Minnesotans who could be negatively affected by Section 708 of Food and Drug Administration Innovation and Safety Act, which allows for the seizure and destruction of personally imported medication.

Rico Anderson imports his prescription medicine for Crohn’s disease from Canada, paying $135 for a one month supply. In the U.S., this medicine would cost over $700 a month. That’s almost $7,000 dollars in annual savings. In contemplating having to face higher U.S. prices, Mr. Rico lamented that: “if it gets to a point where you’re deciding if you have to buy your medicine or pay your mortgage or put food on your table what are you going to do?”

The NBC report features Lee Graczyk, lead organizer of RxRights, a prescription affordability advocacy group. Days before the law passed Mr. Graczyk emphasized both the economic and health costs that result from unaffordable medication: “People are using this option because they cannot afford to buy the medications here. If this law passes, they can’t afford to buy the medications and stop taking the medications, they not only put their health at risk, but as a nation, it’s going to cost us more money.”

Visit RxRights.org to learn how Americans can fight back and protect their access to safe personal prescription drug importation from verified online pharmacies.

To compare prices on prescription medication from Canada and other foreign countries visit PharmacyChecker.com.

Share

A new study, reviewed in Medpage Today, finds that seniors falling into the Medicare Part D prescription drug coverage gap, often referred to as the “doughnut hole,” reduced the number of monthly anti-depressant prescriptions they filled by 12.1% compared to those with full coverage. In 2012, Part D plans share drug costs with enrollees up to $2,930. With co-pays, premiums, and deductibles seniors pay about $1,500 up to that point. After $2,930 the doughnut hole begins and plan enrollees pay out-of-pocket until they have spent $4,700 – after which the plans pay for 95% of drug costs.

The study also showed that those in the doughnut hole were more likely to go without other medications. Monthly use of heart failure drugs and anti-diabetics fell by 12.9% and 13.4%, respectively, relative to the group with full drug coverage. The study, Effects of Medicare Part D Coverage On Medication and Medical Treatment On Elderly Beneficiaries With Depression, was published in the July issue of Archives of General Psychiatry.

We’ve previously reported that the doughnut hole is a serious health issue for America’s seniors who are unable to afford needed medication. The new healthcare law offers seniors substantial discounts in the doughnut hole on brand name medications, and by 2020 the doughnut hole will supposedly be closed. The discounts help seniors to access medicine, but the crisis of skipped medicine will persist through the decade. Until then, it’s critical that seniors do not stop taking needed medications.

Medicare enrollees in the doughnut hole face very high drug costs for popular products such as Lexapro, Cymbalta and Abilify, all used to treat depression. These very medications are, on average, 80% less expensive if ordered from the lowest priced verified online pharmacies. See the chart below for price comparisons of verified international online pharmacies and a U.S. bricks and mortar pharmacy.

Prices for Three-month Supplies of Popular Anti-Depressants

Drug U.S. Bricks and Mortar Pharmacy* Lowest Pharmacy-Checker.com Listed Price** Savings Over 3 Months Percent Savings Savings Over 1 Year
Abilify 10 mg $1,881.99 $332.10 $1,549.89 82.35% $6.199.56
Cymbalta 30 mg $637.00 $133.20 $503.80 79.09% $6,199.56
Lexapro 10 mg $351.00 $84.61 $266.40 75.90% $1,065.60
Average: $956.66 $183.30 $773.36 80.84% $3,093

* Pharmacy in New York City, price collected 7/5/2012
**Lowest price listed on PharmacyChecker.com as of 7/5/2012

Share

UPDATE: the video showing Senator’s Snowe’s floor remarks is no longer available. Please consult the congressional record for this date to read Senator Snowe’s full remarks.

In support of Senator John McCain’s amendment to facilitate safe personal drug importation from credentialed online pharmacies, Senator Olympia Snowe spoke comprehensively, passionately and honestly about the issue. Though the amendment did not pass, Americans interested in online pharmacies and drug affordability should be aware of some of Ms. Snowe’s most pertinent points in support of personal drug importation. The full senate floor presentation is available for viewing as well.

  1. “Americans are facing tremendous increases in prescription drug prices for far too long and I think it’s at a point in which Congress should address this issue,” said Senator Snowe.In 2010 AARP found that retail prices for the most popular brand name drugs increased 41.5% while the consumer price index rose just 13%. In other words the cost of prescription drugs rose more than three times as much as the inflation rate.”
  2.  Senator Snowe wisely reminded her colleagues that most of “America’s” drug products are already manufactured overseas. Senator Snowe points out that the very medications America consumes come from manufacturing facilities in over 50 countries and “not all of those facilities are even inspected….”
  3. We need a more competitive pharmaceutical market. Senator Snowe points out (by quoting a former Pfizer CEO) that more competition from imported medication will lead to lower prices, higher quality products, and more innovation.
  4. The amendment is far more modest than previous drug importation bills and only calls for the Secretary of Health and Human Services (HHS) to make a list of approved online pharmacies for personal drug importation but it would not allow for greater “wholesale” drug importation. PharmacyChecker.com already provides such a list that consumers can freely access. Ironically, while Senator Snowe didn’t mention it, the Secretary of Health and Human Services, Kathleen Sebelius, actually published such a list when she was governor of Kansas for a state drug importation program.

 For those interested in learning more about why personal drug importation should be made more available to Americans please watch Senator Snowe’s floor remarks.


Share

On May 14th, an article appeared in ForeignAffairs.com called “Dangerous Doses: Fighting Fraud In The Global Medicine Supply Chain.” Authors Tim Mackey, Bryan Liang, and Tom Cubic simultaneously report on the counterfeit drug threats and tragedies experienced globally while deceptively attempting to link safe international online pharmacies to this problem. Our vice president, Gabriel Levitt responded in Telling the whole truth about online pharmacies. His response is published below.


Telling the whole truth about international online pharmacies

Over a decade of experience and empirical studies [See “Unveiling the Mystery of Online Pharmacies: an Audit Study” in National Bureau of Economic Research] have shown that credentialed international online pharmacies sell safe and affordable medication, not counterfeit drugs, to Americans who otherwise might cut back or not take their medications at all. These credentialed websites work with licensed pharmacies that require a prescription and meet high safety standards for mail-order pharmacy. They just happen not to be located in the United States, which explains their low prices. They are not a part of the counterfeit drug threat but the authors of this article would like you to think that they are

So why do these authors take this position? Although not well disclosed, the two senior authors are directly affiliated with pharmaceutical corporate interests. Pharmaceutical companies in the U.S. do not want their sales undercut by lower cost imports of the same exact medicines they sell here because it negatively affects their profits. No one disputes this. Bryan Liang maintains a leadership position with the Partnership for Safe Medicines (PSM), which is largely funded by pharmaceutical companies and is currently led by the Deputy VP of Public Relations for the Pharmaceutical Researchers and Manufacturers of America (PhRMA). Thomas Cubic is head of the Pharmaceutical Security Institute (PSI), an organization of pharmaceutical company members. I believe the two entities share an office in Virginia.

The pharmaceutical industry has focused a lot of its lobbying muscle against drug importation laws that could help millions of Americans obtain needed medication. The pharmaceutical industry position is advocated on many levels through Liang’s Partnership for Safe Medicines and Cubic’s PSI, as well as through PhRMA and the National Association of Boards of Pharmacy with the goal of preventing non-US online pharmacies from selling to Americans even if they are safe. A careful reader would certainly find their position in this article.

The authors here accurately acknowledge that a majority of the world’s counterfeit drugs and the subsequent sickness and death they cause are found in countries with weak drug regulations and/or enforcement of laws. But they try and equate huge tragedies in developing countries where counterfeit drugs kill hundreds of thousands with the real but different dangers posed by the Internet.

Let’s just make one thing clear: The counterfeit drug problems found through online pharmacies in the rich countries are real but miniscule compared to the tragedies reported about in poorer countries. In fact, examples provided in this article perfectly reflect the sharp dichotomy in the numbers of counterfeit drug victims in the United States and in poorer countries. Eleven years ago one young American named Ryan Haight, 18, tragically died from an overdose of pills purchased online, which he should have never received. But it’s worth noting that the drug, Vicodin, was real – not counterfeit. In this case, the problem was dispensing medications without proper medical supervision – not counterfeit drugs. The people who sold him the Vicodin went to jail. In Niger, a much larger tragedy occurred – 2,500 people died out of 50,000 who were inoculated with bogus medication. Of course this had nothing to do with U.S. drug importation or online pharmacies. One might have expected the authors to mention the 238 Americans who died after ingesting fake Heparin, which was circulating thorough the legal U.S. drug supply in 2007 and 2008. This, too, had nothing to do with online pharmacies but exceeds in victims any reported incidents having to do with the Internet.

The authors would like you to believe that CanadaDrugs.com, a credentialed international online pharmacy, is a part of the counterfeit drug problem so as to foster actions that could block access to such sites. They state that one of its suppliers is responsible for the counterfeit Avastin in the United States. They fail to mention, however that the counterfeit Avastin had nothing to do with online pharmacies, safe or otherwise. As it happens, many pharmacies in the United States have at one time or another unintentionally sold counterfeit medication – including CVS and Walgreens, which is not a reason to shut them down.

The source of the most recent large scale problem with intentionally sold substandard medications distributed in the United States is in fact GlaxoSmithKline. They were fined $750 million for intentionally distributing millions of substandard pills all across the country. These products were manufactured at their facility in Puerto Rico. U.S. Marshalls confiscated $2 billion of products from the plant in 2005, the largest such seizure in history and worth at least four times the value of all drugs imported by Americans from Canada each year.

There is no doubt that companies and people operating websites that purposefully sell fake drugs or even real drugs without a prescription need to be shut down, and in many cases criminally prosecuted. Victims of bogus online pharmacies certainly go underreported and the problem is very serious. But it’s a different problem from the large scale counterfeit operations that are killing hundreds of thousands of people in poorer countries – a crisis that demands immediate action to prevent the next massacre. The UNDOC may in fact be a better venue for international enforcement efforts, as the authors point out, because police actions may exceed the WHO’s mandate. Interpol’s enforcement work in Operation Pangea definitely took out a lot of bad guys – more such efforts are needed. Certainly working in concert, tapping their respective strengths, UNDOC, Interpol, WHO-IMPACT can bring us to a better place where the counterfeit drug threat goes on the decline.

But when it comes to the American pharmaceutical market, we find 48 million Americans not filling a prescription each year due to cost – an underreported crisis from which many die. Some of these Americans seek affordable and genuine medication online from Canada and other countries to acquire needed medication.

To directly address the core of Foreign Affairs readers, we must not allow our foreign policy and multilateral actions to disadvantage American consumers who are struggling or can’t afford prescription medication. So as we ramp up our efforts to stop criminals from infesting the world with fake drugs let’s not enact policies that will block the access of Americans to life saving medications simply because it improves our corporate balance sheets.

Gabriel Levitt

Vice President
PharmacyChecker.com

President
United Nations Association Brooklyn Chapter

Share

PhRMA Criticizes Obama’s New Budget For Requiring More Rebates on Prescription Drugs

“President Obama just released next year’s budget proposal and it has already sparked fierce criticism from the pharmaceutical industry. That’s because the plan would require Big Pharma to give an additional $156 billion in drug rebates over the next decade.” 
 
This news comes from RxRight.org’s latest blog post, entitled Big Pharma balks at President’s proposed budget. Not surprisingly, as articulated by its president, John Castellani, the Pharmaceutical Research and Manufacturers of America is against the rebates and other reforms found in Obama’s budget. One point championed by Mr. Castellani as a reason to criticize President Obama is that the “Medicare Part D is working well for seniors.” While Part D has certainly helped many seniors afford needed medication, the RxRights post, and empirical data, show that millions of seniors still struggle to afford necessary, and sometimes life-saving, prescription drugs because of costs – despite Medicare Part D drugs plans. 
 
In fact, the failure of Medicare Part D is one reason that reputable international online pharmacies remain a lifeline for Medicare enrollees. It appears if Obama’s budget is approved, without changes to his prescription drug rebate requests, then more Americans will forgo the international option in favor of domestic pharmacies. 
Share

PharmacyChecker.com was mentioned this week in a U.S. News and World Report article entitled How to Cut Your Drug Costs. Listed among other effective ways to save money on prescription drugs, the article notes that PharmacyChecker “compares prices of mail-order pharmacies, and can help you find the lowest posted prices.

How to Cut Your Drug Costs reminds readers that buying drugs from Canada – and elsewhere overseas – is technically illegal, but it quotes AARP: “Over the past decade millions of Americans have ignored U.S. law to seek cheaper prices from Canada, most often by mail order.” Notably, AARP found Canadian prices for Lipitor to be about a third less than they are here in the U.S. The fact that the FDA has (to our knowledge) never prosecuted an individual for importing a three-month supply of personal, non-controlled drugs with a valid prescription, means that they too understand the importance of access to safe and affordable medication. (more…)

Share

U.S. Government Fed Up With Pharmaceutical Prices – FDA To The Rescue?

In March of this year the FDA took the unusual step of allowing an “unapproved” compounded drug to remain on the market to explicitly make sure Americans could afford that product. That drug is hydroxyprogesterone caproate, branded by K-V Pharmaceuticals as Makena, the first FDA-approved drug to prevent the risk of preterm birth in certain women. Will more such government interventions continue in support of drug affordability?

According to the Wall Street Journal Blog,“Typically, whenever a drug is approved, pharmacy compounding isn’t allowed and the FDA acts to remove any unapproved drugs that might on be the U.S. market.” However, the FDA is allowing the compound to remain solely because of the outrageous cost for the brand-name product; Makena is priced at $1,500 per dose! Before Makena was approved, the same drug without the K-V branding and FDA stamp of approval cost between $10 – 20 per dose.

To the best of our knowledge, the FDA’s role does not include controlling prices to help Americans have access to the medication they need. However, that is precisely what the FDA did in the case of Makena. In our opinion, that’s also what the FDA does by not enforcing certain personal drug importation laws that, if enforced, would prevent Americans from affording needed medication. Currently, under its personal drug importation policy, the FDA has stated it does not take enforcement action against individuals who import non-controlled medicines, which are generally (and ironically) viewed as not FDA-approved even if they’re the exact same drug sold here, often due to labelling or pill color and shape differences between otherwise identical products. (more…)

Share
Get Adobe Flash playerPlugin by wpburn.com wordpress themes